Most of the job cuts will be in Cambridge, Mass., the hub of Amgen’s neuroscience research, but some research and development positions in Thousand Oaks, Calif., and South San Francisco also will be affected.
Amgen’s exit from neuroscience research follows such other industry leaders as GlaxoSmithKline, Pfizer and AstraZeneca, which recently ended their work on neurological diseases.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
